Overview

Christopher Nolan’s new film “The Odyssey” is slated to open in theaters on Friday, with worldwide box‑office projections of approximately $200 million for the opening weekend, representing the director’s largest debut since “The Dark Knight Rises” in 2012.

Impact on IMAX

IMAX Corp. (ticker IMX) is the most direct financial beneficiary because the film is the first feature shot entirely on IMAX 70 mm cameras. Only 41 theatres worldwide – 25 in the United States – are equipped to project the movie in its native format. CEO Richard Gelfond told Variety that several screenings are sold out into the fifth week, including unconventional 2 am and 7 am showings, and noted that no new IMAX film projectors have been manufactured in roughly 50 years. The stock rose 1.18% following the news.

Theatre‑Chain Exposure

The film is expected to generate $90 million to $100 million domestically across roughly 3,900 North American screens. AMC Entertainment Holdings Inc. (ticker AMC) received an upgrade from Texas Capital Securities on 15 July, moving from Hold to Buy and raising the price target from $2.00 to $3.00. The upgrade cited the resolution of near‑term debt maturities and a strengthening box‑office environment; AMC shares advanced 5.1% in pre‑market trading. Macquarie also raised its full‑year 2026 industry box‑office forecast, highlighting that Q2 U.S. admissions revenue was the strongest second‑quarter domestic performance in six years.

Marcus Corp. (ticker MCS), a regional theatre and hotel operator, saw its Q2 2026 revenue estimate lifted to $216.5 million (consensus $209.4 million) after reporting 11.2% year‑over‑year domestic box‑office growth to $2.934 billion. Benchmark reiterated a Buy rating with a $22 price target, and Marcus shares have risen 41% year‑to‑date. Cinemark Holdings Inc. (ticker CNK) is also positioned to benefit given its presence on the 3,900 screens, though no specific uplift commentary was available.

Industry Context

The Financial Times noted that “The Odyssey” is driving a box‑office surge toward pre‑pandemic summer levels, with the 2026 summer season projected to be the strongest since 2019 as production capacity rebounds after pandemic‑era disruptions and industry strikes. Universal Pictures produced the film at a production cost of $250 million and an estimated $125 million in global marketing spend, making a sustained multi‑week theatrical run commercially essential. Variety emphasized that the studio needs the film to enjoy a box‑office run “as long (but maybe not as arduous) as Odysseus’ journey back to Ithaca.”

Upcoming Data Points

Domestic opening‑weekend actuals are expected on Sunday and Monday, which will confirm or adjust the $90‑$100 million estimate and set the tone for exhibition‑sector equities early the following week. IMAX’s Q2 2026 earnings are scheduled for release before the market opens on Thursday, 23 July. Analysts project earnings per share of $0.30 and revenue of $95.89 million, up from Q1 2026 EPS of $0.17 and revenue of $81.38 million. Management’s commentary on premium IMAX ticket sales from “The Odyssey” will be a focal point for investors.

Stock Movements (as reported)

  • IMAX Corp. (IMX) +1.18%
  • AMC Entertainment (AMC) +7.36%
  • Marcus Corp. (MCS) –0.20%
  • Cinemark (CNK) +0.23%